Brief: Arrowhead Pharmaceuticals Files Complaint For Declaratory Judgment Against Ionis Pharmaceuticals
11/09/2025 12:43
Sept 11 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O: ARROWHEAD PHARMACEUTICALS: FILES COMPLAINT FOR DECLARATORY JUDGMENT AGAINST IONIS PHARMACEUTICALS ARROWHEAD PHARMACEUTICALS: NOT SEEKING MONETARY RELIEF IN COMPLAINT AGAINST IONIS PHARMACEUTICALS Source text: ID:nBw15MFmga Further company coverage: ARWR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
US FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment
Focus: AI companies run virtual drug trials, aim to improve success of human studies
Brief: Ionis Pharmaceuticals Says Ulefnersen Demonstrates Favorable Safety And Tolerability Profile
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study